BridgeBio Pharma, Inc. (BBIO) Revenue Growth
BridgeBio Pharma, Inc. (BBIO) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | -79.66% |
| 2021-12-31 | 745.14% |
| 2022-12-31 | 11.38% |
| 2023-12-31 | -88.02% |
| 2024-12-31 | 2285.27% |
| 2025-12-31 | 126.26% |
How BBIO compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| BCRX | BioCryst Pharmaceuticals Inc. | 94.10% |
| TGTX | TG Therapeutics Inc. | 87.32% |
| AXSM | Axsome Therapeutics Inc. | 65.55% |
| ALNY | Alnylam Pharmaceuticals Inc. | 65.19% |
These are five companies in the same sector as BBIO with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BridgeBio Pharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("BBIO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BBIO | $74.84 | -0.76% | 1.54M |
| 3 | ||||
| 4 | ||||
| 5 |